Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia
Authors:
- Alaadin VögeliAVAlaadin Vögeli
- Manuel OttigerMOManuel Ottiger
- Marc A. MeierMMMarc A. Meier
- Christian SteuerCSChristian Steuer
- Luca BernasconiLBLuca Bernasconi
- Andreas HuberAHAndreas Huber
- Mirjam Christ-CrainMCMirjam Christ-Crain
- Christoph HenzenCHChristoph Henzen
- Claus HoessCHClaus Hoess
- Robert ThomannRTRobert Thomann
- Werner ZimmerliWerner Zimmerli
Open Access
- 23 January 2017
- journal article
- research article
- Published by Springer Nature in Respiratory Research
- Vol. 18 (1) , 25
Abstract
During infection, there is an activation of the L-arginine-nitric-oxide pathway, with a shift from nitric oxide synthesis to a degradation of L-arginine to its metabolites, asymmetric and symmetric dimethylarginine (ADMA and SDMA). However, the prognostic implications for short-term or long-term survival remains unclear. We investigated the association of L-arginine, ADMA, and SDMA with adverse clinical outcomes in a well-defined cohort of patients with community-acquired pneumonia (CAP). We measured L-arginine, ADMA, and SDMA in 268 CAP patients from a Swiss multicenter trial by mass spectrometry and used Cox regression models to investigate associations between blood marker levels and disease severity as well as mortality over a period of 6 years. Six-year mortality was 44.8%. Admission levels of ADMA and SDMA (μmol/L) were correlated with CAP severity as assessed by the pneumonia severity index (r = 0.32, p < 0.001 and r = 0.56, p < 0.001 for ADMA and SDMA, respectively) and higher in 6-year non-survivors versus survivors (median 0.62 vs. 0.48; p < 0.001 and 1.01 vs. 0.85; p < 0.001 for ADMA and SDMA, respectively). Both ADMA and SDMA were significantly associated with long-term mortality (hazard ratios [HR] 4.44 [95% confidence intervals (CI) 1.84 to 10.74] and 2.81 [95% CI 1.45 to 5.48], respectively). The effects were no longer significant after multivariate adjustment for age and comorbidities. No association of L-arginine with severity and outcome was found. Both ADMA and SDMA show a severity-dependent increase in patients with CAP and are strongly associated with mortality. This association is mainly explained by age and comorbidities. ISRCTN95122877 . Registered 31 July 2006.Keywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNSF Professorship, PP00P3_150531 / 1)
- Research Council of the Kantonsspital Aarau (1410.000.044)
This publication has 45 references indexed in Scilit:
- Diabetic nephropathy is resistant to oral l-arginine or l-citrulline supplementationAmerican Journal of Physiology-Renal Physiology, 2014
- ADMA/SDMA in Elderly Subjects with Asymptomatic Carotid Atherosclerosis: Values and Site-Specific AssociationInternational Journal of Molecular Sciences, 2014
- The methylarginines NMMA, ADMA, and SDMA are ubiquitous constituents of the main vegetables of human nutritionNitric Oxide, 2013
- Cardiac Complications in Patients With Community-Acquired PneumoniaCirculation, 2012
- ADMA, SDMA and L-arginine/ADMA Ratio but not DDAH Genetic Polymorphisms are Reliable Predictors of Diabetic Nephropathy Progression as Identified by Competing Risk AnalysisKidney and Blood Pressure Research, 2012
- Asymmetric Dimethylarginine Is Increased in AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2011
- The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular DiseaseCurrent Cardiology Reviews, 2010
- Chapter 3 The Emerging Role of Symmetric Dimethylarginine in Vascular Disease2009
- Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trialBMC Health Services Research, 2007
- Effect of preoperative oral immune-enhancing nutritional supplement on patients at high risk of infection after cardiac surgery: a randomised placebo-controlled trialThe Lancet, 2001